Sagimet Biosciences Inc. Net Income (Loss) Attributable to Parent in USD from Q1 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sagimet Biosciences Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q3 2025.
  • Sagimet Biosciences Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$12.9M, a 11.7% increase year-over-year.
  • Sagimet Biosciences Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$57.7M, a 53.7% decline year-over-year.
  • Sagimet Biosciences Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$45.6M, a 63.5% decline from 2023.
  • Sagimet Biosciences Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$27.9M, a 8.6% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Sagimet Biosciences Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$57.7M -$12.9M +$1.71M +11.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 -$59.4M -$10.4M -$2.27M -27.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-13
Q1 2025 -$57.1M -$18.2M -$11.5M -174% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-13
Q4 2024 -$45.6M -$16.2M -$8.05M -98.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-12
Q3 2024 -$37.5M -$14.6M -$8.27M -130% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$29.3M -$8.12M -$1.33M -19.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-13
Q1 2024 -$27.9M -$6.63M -$42K -0.64% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-13
Q4 2023 -$27.9M -$8.15M -$956K -13.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-12
Q3 2023 -$26.9M -$6.35M +$1.11M +14.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$28M -$6.79M +$317K +4.46% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$28.4M -$6.59M +$2.15M +24.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$30.5M -$7.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$7.47M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$7.1M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$8.74M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13

Sagimet Biosciences Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$45.6M -$17.7M -63.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-12
2023 -$27.9M +$2.62M +8.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-12
2022 -$30.5M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.